Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Lachmann

Showing results (121-130 of 287) with videos related to

Pageof 29
Sort By:
Biochemical Society Transactions|May 1, 1997
Complement in IgA immune-complex-induced neutrophil activationW Zhang, Y M Lucisano, P J Lachmann
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1994
Complement component C7. Assessment of in vivo synthesis after liver transplantation reveals that hepatocytes do not synthesize the majority of human C7R Würzner, V C Joysey, P J Lachmann
Clinical and Experimental Immunology|September 1, 1987
Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surfaceM Walport, Y C Ng, P J Lachmann
Nature|July 12, 1974
Restoration of specific immunological virginityI McConnell, P J Lachmann, M J Hobart
Immunochemistry|October 1, 1973
Further studies on the C3b inactivator or conglutinogen activating factor (KAF)P J Lachmann, P Nicol, W P Aston
Journal of Immunogenetics|June 1, 1978
Inherited structural variation and linkage relationships of C7M J Hobart, V Joysey, P J Lachmann
Clinical and Experimental Immunology|November 1, 1977
The activation of the C3b feedback cycle with human complement components. I. Through the classical pathwayL W Mak, P J Lachmann, J Majewski
Clinical and Experimental Immunology|November 1, 1977
The activation of the C3b feedback cycle with human complement components. II. Using components of the alternative pathwayL W Mak, J Majewski, P J Lachmann
Biochemical and Biophysical Research Communications|October 16, 1989
A novel strategy for producing chimeric bispecific antibodies by gene transfectionS Songsivilai, P M Clissold, P J Lachmann
Scandinavian Journal of Immunology|March 1, 1988
The killing of tumour cell targets coupled to tuberculin (PPD) by human and murine PPD-reactive T helper clones. I. PPD specificity of killingA Vyakarnam, P J Lachmann, D Y Sia
Pageof 29

Showing results (121-130 of 287) with videos related to

Sort By:
Pageof 29
Biochemical Society Transactions|May 1, 1997
Complement in IgA immune-complex-induced neutrophil activationW Zhang, Y M Lucisano, P J Lachmann
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1994
Complement component C7. Assessment of in vivo synthesis after liver transplantation reveals that hepatocytes do not synthesize the majority of human C7R Würzner, V C Joysey, P J Lachmann
Clinical and Experimental Immunology|September 1, 1987
Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surfaceM Walport, Y C Ng, P J Lachmann
Nature|July 12, 1974
Restoration of specific immunological virginityI McConnell, P J Lachmann, M J Hobart
Immunochemistry|October 1, 1973
Further studies on the C3b inactivator or conglutinogen activating factor (KAF)P J Lachmann, P Nicol, W P Aston
Journal of Immunogenetics|June 1, 1978
Inherited structural variation and linkage relationships of C7M J Hobart, V Joysey, P J Lachmann
Clinical and Experimental Immunology|November 1, 1977
The activation of the C3b feedback cycle with human complement components. I. Through the classical pathwayL W Mak, P J Lachmann, J Majewski
Clinical and Experimental Immunology|November 1, 1977
The activation of the C3b feedback cycle with human complement components. II. Using components of the alternative pathwayL W Mak, J Majewski, P J Lachmann
Biochemical and Biophysical Research Communications|October 16, 1989
A novel strategy for producing chimeric bispecific antibodies by gene transfectionS Songsivilai, P M Clissold, P J Lachmann
Scandinavian Journal of Immunology|March 1, 1988
The killing of tumour cell targets coupled to tuberculin (PPD) by human and murine PPD-reactive T helper clones. I. PPD specificity of killingA Vyakarnam, P J Lachmann, D Y Sia
Pageof 29